Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9533
+0.0748 (8.51%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $36.89 million as of April 23, 2025. Its market cap has decreased by -8.41% in one year.
Market Cap
36.89M
Enterprise Value
35.97M
1-Year Change
-8.41%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $36.89M, an increase of 1,975.00%. That is a compound annual growth rate of 234.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 36.89M | -15.04% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.92B |
| UnitedHealth Group | 386.05B |
| Johnson & Johnson | 380.68B |
| AbbVie | 304.41B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.46B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |